Home / Recalls / US Compounding Inc / D-0249-2016

D-0249-2016 Class II Terminated

Recalled by US Compounding Inc — Conway, AR

FDA drug recall D-0249-2016 was initiated by US Compounding Inc on Sep 12, 2015 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance. The recall status is terminated (terminated Mar 30, 2017). Affected quantity: 854 vials.

Recall Details

Product Type: Drugs
Report Date: Nov 25, 2015
Initiation Date: Sep 12, 2015
Termination Date: Mar 30, 2017
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 854 vials

Product Description

Dex Combo (Dexamethasone acetate 8mg/mL, dexamethasone sodium phosphate USP, 4 mg/mL),30 mL Multi-Dose Vial, For IM & Regional Injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3057-06

Reason for Recall

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Distribution Pattern

Nationwide

Code Information

Lot Numbers: 20150705@1 BUD: 11/2/2015; 20151706@49 BUD: 12/14/2015; 20152204@21 BUD: 10/19/2015; 20152303@26 BUD: 9/19/2015

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0249-2016
openFDA file date: Nov 3, 2026
Loaded by RegDataLab: Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by US Compounding Inc

D-0223-2021 Class III — Succinylcholine Chloride PF Inj. 200 mg/10 mL, 10 mL single use syringes, Rx… (Dec 16, 2020)
D-0175-2021 Class III — Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes… (Nov 25, 2020)
D-0508-2019 Class II — Ephedrine Sulfate, 50 mg/10 mL, 10 mL Single Use Syringe, Rx only, US… (Jan 29, 2019)
D-0482-2019 Class II — LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL… (Jan 24, 2019)
D-0219-2017 Class I — Docusate Oral 10 mg/mL Oral Syringe, packaged in a) 1 mL (62295-0601-01), b) 2… (Jul 25, 2016)
D-0276-2016 Class II — Phenylephrine PF (1 mg/10 mL), 10 mL Single Use Syringe, For IV Use, Rx only… (Sep 12, 2015)
D-0245-2016 Class II — Cyclo/PE/Tropic/Ketor (1%/2.5%/1%/0.5%), 10 mL Opthalmic dropper bottle, For… (Sep 12, 2015)
D-0270-2016 Class II — Morphine PF (2 mg/2 mL), 2 mL Single Use Vial, For IV or IM Administration, Rx… (Sep 12, 2015)
D-0286-2016 Class II — Triamcinolone diacetate USP (40 mg/mL), 30 mL Multi-Dose Vial, For IM & Regional… (Sep 12, 2015)
D-0253-2016 Class II — Glycopyrrolate USP ( 1 mg/5 mL), 5 mL Single Use syringe, For IM or IV… (Sep 12, 2015)